Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Profit After Tax: 2022-2024

Historic Profit After Tax for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to -$61.0 million.

  • Orchestra BioMed Holdings' Profit After Tax fell 35.02% to -$20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.1 million, marking a year-over-year decrease of 30.19%. This contributed to the annual value of -$61.0 million for FY2024, which is 24.23% down from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Profit After Tax is -$61.0 million, which was down 24.23% from -$49.1 million recorded in FY2023.
  • Orchestra BioMed Holdings' 5-year Profit After Tax high stood at -$33.6 million for FY2022, and its period low was -$61.0 million during FY2024.
  • Its 3-year average for Profit After Tax is -$47.9 million, with a median of -$49.1 million in 2023.
  • Data for Orchestra BioMed Holdings' Profit After Tax shows a maximum YoY plummeted of 46.16% (in 2023) over the last 5 years.
  • Orchestra BioMed Holdings' Profit After Tax (Yearly) stood at -$33.6 million in 2022, then tumbled by 46.16% to -$49.1 million in 2023, then dropped by 24.23% to -$61.0 million in 2024.